Siena Biotech's Business model actively capitalizes on partnering as a key tool for corporate development and to achieve success in our research efforts. In the first years of its activities, Siena Biotech has already forged partnerships with both established pharmaceutical companies and biotech firms. The business of science, especially life sciences, carries high risks and rewards, both in terms of successful therapeutic advancements to reduce human suffering and in terms of market availability of such therapies. Success rate is maximized as motivated partners, sharing an interest in the same disease, integrate their best know-how to create a partnership pointing towards a common therapeutic objective.

We have made this principle the leitmotiv of our partnering strategy: we are looking for companies and corporations willing to forge R&D agreements in neurodegenerative and proliferative disorders, with risk/reward sharing models. Our core interest is in orphan diseases as well as in more common neurological disorders and in brain tumours. If you believe these may be the basis to discuss a partnership with Siena Biotech, please contact us: we'll be glad to discuss your proposal.

For partnering contact us: info@sienabiotech.it